qbrelis

Generic: lisinopril

Labeler: azurity pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name qbrelis
Generic Name lisinopril
Labeler azurity pharmaceuticals, inc.
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

lisinopril 1 mg/mL

Manufacturer
Azurity Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 52652-3001
Product ID 52652-3001_461e97d5-c8b3-75a7-e063-6394a90a6ec6
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA208401
Listing Expiration 2026-12-31
Marketing Start 2016-08-29

Pharmacologic Class

Classes
angiotensin converting enzyme inhibitor [epc] angiotensin-converting enzyme inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 526523001
Hyphenated Format 52652-3001

Supplemental Identifiers

RxCUI
1806884 1806890
UNII
E7199S1YWR

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name qbrelis (source: ndc)
Generic Name lisinopril (source: ndc)
Application Number NDA208401 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 1 mg/mL
source: ndc
Packaging
  • 150 mL in 1 BOTTLE (52652-3001-1)
source: ndc

Packages (1)

52652-3001-1 150 mL in 1 BOTTLE (52652-3001-1)

Ingredients (1)

lisinopril (1 mg/mL)

Linked Drug Pages (1)

Qbrelis ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "461e97d5-c8b3-75a7-e063-6394a90a6ec6", "openfda": {"unii": ["E7199S1YWR"], "rxcui": ["1806884", "1806890"], "spl_set_id": ["9f6e4e57-a489-4b36-b093-b93865d3717c"], "manufacturer_name": ["Azurity Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "150 mL in 1 BOTTLE (52652-3001-1)", "package_ndc": "52652-3001-1", "marketing_start_date": "20160829"}], "brand_name": "Qbrelis", "product_id": "52652-3001_461e97d5-c8b3-75a7-e063-6394a90a6ec6", "dosage_form": "SOLUTION", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]"], "product_ndc": "52652-3001", "generic_name": "lisinopril", "labeler_name": "Azurity Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Qbrelis", "active_ingredients": [{"name": "LISINOPRIL", "strength": "1 mg/mL"}], "application_number": "NDA208401", "marketing_category": "NDA", "marketing_start_date": "20160829", "listing_expiration_date": "20261231"}